167 related articles for article (PubMed ID: 32504276)
1. Low-cost Fluorescein as an Alternative to Radio-colloid for Sentinel Lymph Node Biopsy-a Prospective Validation Study in Early Breast Cancer.
Valiveru RC; Agarwal G; Agrawal V; Gambhir S; Mayilvaganan S; Chand G; Mishra A; Agarwal A; Mishra SK
World J Surg; 2020 Oct; 44(10):3417-3422. PubMed ID: 32504276
[TBL] [Abstract][Full Text] [Related]
2. Validation sentinel lymph node biopsy study in cN0 axilla using low-cost dual dye technique: potential solution for resource poor settings.
Chavda J; Mishra A; Silodia A; Yadav SK; Sharma DB; Sharma D; Khandare M
Breast Cancer Res Treat; 2022 May; 193(1):105-110. PubMed ID: 35246773
[TBL] [Abstract][Full Text] [Related]
3. A Comparative Validation of Primary Surgical Versus Post-neo-adjuvant Chemotherapy Sentinel Lymph Node Biopsy for Stage III Breast Cancers.
Agarwal G; Rajan S; Gambhir S; Lal P; Krishnani N; Kheruka S
World J Surg; 2016 Jul; 40(7):1583-9. PubMed ID: 26324160
[TBL] [Abstract][Full Text] [Related]
4. Can Low-cost Indo Cyanine Green Florescence Technique for Sentinel Lymph Node Biopsy Replace Dual Dye (Radio-colloid and Blue Dye) Technique in Early Breast Cancer: A Prospective Two-arm Comparative Study.
Somashekhar SP; Kumar CR; Ashwin KR; Zaveri SS; Jampani A; Ramya Y; Parameswaran R; Rakshit S
Clin Breast Cancer; 2020 Oct; 20(5):e576-e583. PubMed ID: 32389561
[TBL] [Abstract][Full Text] [Related]
5. Prospective Randomized Trial of Use of In-House Prepared Low-Cost Radiopharmaceutical Versus Commercial Radiopharmaceutical for Sentinel Lymph Node Biopsy in Patients with Early Stage Invasive Breast Cancer.
Agarwal G; Rajan S; Mayilvaganan S; Mishra A; Krishnani N; Gambhir S
World J Surg; 2018 May; 42(5):1391-1395. PubMed ID: 29383426
[TBL] [Abstract][Full Text] [Related]
6. Radio-guided sentinel lymph node biopsy using periareolar injection technique for patients with early breast cancer.
Yen RF; Kuo WH; Lien HC; Chen TH; Jan IS; Wu YW; Wang MY; Chang KJ; Huang CS
J Formos Med Assoc; 2007 Jan; 106(1):44-50. PubMed ID: 17282970
[TBL] [Abstract][Full Text] [Related]
7. Concordance and validation study of sentinel lymph node biopsy for breast cancer using subareolar injection of blue dye and technetium 99m sulfur colloid.
Kern KA
J Am Coll Surg; 2002 Oct; 195(4):467-75. PubMed ID: 12375751
[TBL] [Abstract][Full Text] [Related]
8. Application of fluorescein combined with methylene blue in sentinel lymph node biopsy of breast cancer.
Li L; Gao N; Yang AQ; Xu WH; Ding Y; Chu J; Lin XN; Liu JQ
Sci Rep; 2021 Jun; 11(1):12119. PubMed ID: 34108563
[TBL] [Abstract][Full Text] [Related]
9. Improved false-negative rates using a novel patient selection flowchart in initially biopsy-proven node-positive breast cancer undergoing blue-dye alone guided sentinel lymph node biopsy after neoadjuvant chemotherapy.
Chen M; Li S; Huang M; Guo J; Huang X; Guo W; Chen L; Lin Y; Jacobs L; Wang C; Fu F
Breast Cancer Res Treat; 2022 Nov; 196(2):267-277. PubMed ID: 36100784
[TBL] [Abstract][Full Text] [Related]
10. Retrospective analysis of sentinel lymph node biopsy using methylene blue dye for early breast cancer.
Yang S; Xiang HY; Xin L; Zhang H; Zhang S; Cheng YJ; Liu Q; Xu L; Li T; Duan XN; Ye JM; Liu YH
Chin Med J (Engl); 2021 Jan; 134(3):318-325. PubMed ID: 33522727
[TBL] [Abstract][Full Text] [Related]
11. Factors affecting failed localisation and false-negative rates of sentinel node biopsy in breast cancer--results of the ALMANAC validation phase.
Goyal A; Newcombe RG; Chhabra A; Mansel RE;
Breast Cancer Res Treat; 2006 Sep; 99(2):203-8. PubMed ID: 16541308
[TBL] [Abstract][Full Text] [Related]
12. [Application of methylene blue dye to sentinel lymph node biopsy in breast cancer and its influencing factors].
Huang XY; Wu J; Liu ZB; Zhang JX; Han QX; Xu WP; Ping B; Yang WT; Shen ZZ; Shao ZM
Ai Zheng; 2007 Oct; 26(10):1133-7. PubMed ID: 17927887
[TBL] [Abstract][Full Text] [Related]
13. Clinicopathologic analysis of sentinel lymph node mapping in early breast cancer.
Choi SH; Barsky SH; Chang HR
Breast J; 2003; 9(3):153-62. PubMed ID: 12752622
[TBL] [Abstract][Full Text] [Related]
14. Sentinel lymph node biopsy for breast cancer using methylene blue dye manifests a short learning curve among experienced surgeons: a prospective tabular cumulative sum (CUSUM) analysis.
East JM; Valentine CS; Kanchev E; Blake GO
BMC Surg; 2009 Jan; 9():2. PubMed ID: 19173714
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic Performance of Indocyanine Green Plus Methylene Blue Versus Radioisotope Plus Methylene Blue Dye Method for Sentinel Lymph Node Biopsy in Node-Negative Early Breast Cancer.
Agrawal SK; Hashlamoun I; Karki B; Sharma A; Arun I; Ahmed R
JCO Glob Oncol; 2020 Jul; 6():1225-1231. PubMed ID: 32749861
[TBL] [Abstract][Full Text] [Related]
16. Prospective study found that peripheral lymph node sampling reduced the false-negative rate of sentinel lymph node biopsy for breast cancer.
Han C; Yang B; Zuo WS; Liu YS; Zheng G; Yang L; Zheng MZ
Chin J Cancer; 2016 Apr; 35():35. PubMed ID: 27044285
[TBL] [Abstract][Full Text] [Related]
17. Sentinel lymphnode biopsy in early breast cancer using methylene blue dye and radioactive sulphur colloid - a single institution Indian experience.
Somashekhar SP; Zaveri Shabber S; Udupa Venkatesh K; Venkatachala K; Parameshwaran ; Vasan Thirumalai MM
Indian J Surg; 2008 Jun; 70(3):111-9. PubMed ID: 23133037
[TBL] [Abstract][Full Text] [Related]
18. Methylene blue dye as an alternative to isosulfan blue dye for sentinel lymph node localization.
Simmons R; Thevarajah S; Brennan MB; Christos P; Osborne M
Ann Surg Oncol; 2003 Apr; 10(3):242-7. PubMed ID: 12679308
[TBL] [Abstract][Full Text] [Related]
19. Subareolar blue dye only injection sentinel lymph node biopsy could reduce the numbers of standard axillary lymph node dissection in environments without access to nuclear medicine.
Kavallaris A; Camara O; Runnebaum IB
J Cancer Res Clin Oncol; 2008 Jun; 134(6):667-72. PubMed ID: 18026990
[TBL] [Abstract][Full Text] [Related]
20. Dye- and gamma probe-guided sentinel lymph node biopsy in breast cancer patients: using patent blue dye and technetium-99m-labeled human serum albumin.
Tsugawa K; Noguchi M; Miwa K; Bando E; Yokoyama K; Nakajima K; Michigishi T; Tonami N; Minato H; Nonomura A
Breast Cancer; 2000 Jan; 7(1):87-94. PubMed ID: 11029778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
